For example, BRAF inhibition in melanoma patients has been shown to cause CAF-mediated ECM remodeling, which supports melanoma growth and promotes BRAF-inhibitor resistance by upregulating integrin β1/FAK/Src signaling [296]. This evidence concerns the gene PTK2 and melanoma.